These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 22841133)

  • 41. Response to Schiano et al. Hepatoportal sclerosis as a cause of noncirrhotic portal hypertension in patients with HIV.
    Mallet VO; Bralet MP; Pol S
    Am J Gastroenterol; 2008 Mar; 103(3):808-9. PubMed ID: 18341510
    [No Abstract]   [Full Text] [Related]  

  • 42. Mercaptopurine-induced fever in a patient with Crohn's disease.
    Rehr EL; Swanson KA; Kern JA
    Ann Pharmacother; 1992; 26(7-8):907-9. PubMed ID: 1504396
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [When is drug therapy with azathioprine indicated in Crohn's disease?].
    Rogler G; Herfarth H
    Dtsch Med Wochenschr; 2002 May; 127(22):1213-4. PubMed ID: 12035120
    [No Abstract]   [Full Text] [Related]  

  • 44. [Association of hepatic adenomatosis and hepatoportal sclerosis in a woman with incontinentia pigmenti].
    Oberti F; Rifflet H; Fléjou JF; Leclech C; Belghiti J; Rousselet MC; Calès P
    Gastroenterol Clin Biol; 1997; 21(2):147-51. PubMed ID: 9161481
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Nodular regenerative hyperplasia in inflammatory bowel disease patients with allopurinol-thiopurine cotherapy.
    Simsek M; Seinen ML; de Boer NKH
    Eur J Gastroenterol Hepatol; 2018 Oct; 30(10):1254-1255. PubMed ID: 30063483
    [No Abstract]   [Full Text] [Related]  

  • 46. Routinely Established Skewed Thiopurine Metabolism Leads to a Strikingly High Rate of Early Therapeutic Failure in Patients With Inflammatory Bowel Disease.
    Kreijne JE; Seinen ML; Wilhelm AJ; Bouma G; Mulder CJ; van Bodegraven AA; de Boer NK
    Ther Drug Monit; 2015 Dec; 37(6):797-804. PubMed ID: 25853923
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Azathioprine and 6-mercaptopurine for Crohn's disease.
    Lancet; 1980 Aug; 2(8189):298-9. PubMed ID: 6105443
    [No Abstract]   [Full Text] [Related]  

  • 48. Risk of lymphoma in patients with inflammatory bowel disease treated with azathioprine and 6-mercaptopurine: a meta-analysis.
    Kotlyar DS; Lewis JD; Beaugerie L; Tierney A; Brensinger CM; Gisbert JP; Loftus EV; Peyrin-Biroulet L; Blonski WC; Van Domselaar M; Chaparro M; Sandilya S; Bewtra M; Beigel F; Biancone L; Lichtenstein GR
    Clin Gastroenterol Hepatol; 2015 May; 13(5):847-58.e4; quiz e48-50. PubMed ID: 24879926
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Nodular regenerative hyperplasia as a side effect of azathioprine in a patient with Crohn's disease].
    Schumann M; Preiss JC; Loddenkemper C; Günther U; Somasundaram R; Siegmund B; Zeitz M
    Dtsch Med Wochenschr; 2008 Sep; 133(38):1897-900. PubMed ID: 18788068
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Idiopathic non-cirrhotic portal hypertension (INCPH) during azathioprine treatment in patient with Crohn's disease: A case report.
    Chabbouh K; Cherif D; Debbabi H; Kchir H; Hassine H; Ben-Hammamia S; Lakhoua G; Jarray A; Frikha W; Chelly B; El-Aidli S; Mizouni H; Haouet S; Maamouri N
    Therapie; 2022; 77(4):489-491. PubMed ID: 34454746
    [No Abstract]   [Full Text] [Related]  

  • 51. [Anatomo-clinical case. Idiopathic portal hypertension (hepatoportal sclerosis)].
    Aguirre-García J; Cervantes LF; Stoopen M
    Arch Invest Med (Mex); 1971; 2(3):499-510. PubMed ID: 5170765
    [No Abstract]   [Full Text] [Related]  

  • 52. The development of hepatoportal sclerosis and portal hypertension due to didanosine use in HIV.
    Schiano TD; Uriel A; Dieterich DT; Fiel MI
    Virchows Arch; 2011 Feb; 458(2):231-5. PubMed ID: 21057809
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Hepatotoxicity associated with 6-thioguanine therapy for Crohn's disease.
    Rulyak SJ; Saunders MD; Lee SD
    J Clin Gastroenterol; 2003 Mar; 36(3):234-7. PubMed ID: 12590235
    [TBL] [Abstract][Full Text] [Related]  

  • 54. WAGR syndrome in a baby--the result of 6-MP treatment in a father affected by Crohn's disease?
    Ben-Neriah Z; Ackerman Z
    Am J Gastroenterol; 2001 Jan; 96(1):251. PubMed ID: 11197266
    [No Abstract]   [Full Text] [Related]  

  • 55. Acute myeloblastic leukemia following prolonged treatment of Crohn's disease with 6-mercaptopurine.
    Heizer WD; Peterson JL
    Dig Dis Sci; 1998 Aug; 43(8):1791-3. PubMed ID: 9724170
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Nodular regenerative hyperplasia: a reversible entity associated with azathioprine therapy.
    Seiderer J; Zech CJ; Diebold J; Schoenberg SO; Brand S; Tillack C; Göke B; Ochsenkühn T
    Eur J Gastroenterol Hepatol; 2006 May; 18(5):553-5. PubMed ID: 16607155
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Azathioprine induced pancreatitis, polyarthritis and panniculitis (PPP) syndrome in a patient with Crohn's disease.
    Mishra S; Garg S; Mahajan R; Patil A; Bhatia P; Sharma V
    Acta Gastroenterol Belg; 2020; 83(1):87-89. PubMed ID: 32233278
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Alcohol binging causes peliosis hepatis during azathioprine therapy in Crohn's disease.
    Elsing C; Placke J; Herrmann T
    World J Gastroenterol; 2007 Sep; 13(34):4646-8. PubMed ID: 17729423
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The impact of medical therapy for inflammatory bowel disease on pregnancy outcome.
    Simpson PW; Melmed GY; Dubinksy M
    Am J Gastroenterol; 2008 Mar; 103(3):805-6. PubMed ID: 18341506
    [No Abstract]   [Full Text] [Related]  

  • 60. Role of thiopurines as disease-modifying agents in Crohn's disease.
    Blackwell J; Saxena S; Pollok RC
    Gut; 2018 Dec; 67(12):2229-2230. PubMed ID: 29298871
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.